JFIFC    $ &%# #"(-90(*6+"#2D26;=@@@&0FKE>J9?@=C  =)#)==================================================q" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?o>{Gʖ iA%HAY-BGe:wFc5+Br: qT떚*[u|?2޿Z֒C< d]g7ʊ:5XrK #ji Vk;w?O|Spd&i`Im\A._U3o?bmU?}[A̭H}Vҭ^TLTeXr+*l3/,jl@ԓ$+/,IzmMZ(|Vw'qzYuI'ʟ׊*4DV,(OöZueu.B@ZumZP%v \y,./[kI>7rF9A=ًmhͰ-ݾp' U=*?=sxIF?qyVTNbBqKJ8/KF5vK>Js_qȜ!V֏]).mN'Rs娾ŞpMH|?s/5A%*[|GlvTwʤoSs=Qȳ+pX@T:+z+^?1xN1ץM)`WzAj=TΐsD.WmGKG9jƬEm Kl\cp'ᨮsŖz6Qd 1%5E!h]vQv^>ymCkiYf4I>ݫм3~ӭV:ܷZO]Ts̴_ j5Lwo5q%0L1lkF dߥWXne 4ܸ özgڹkP9ji$&}[1 kӿ%cH3SZOgiil9V"QGm#+4*A{֫k}ަ)1RA+r"f) mk[^M_δ;K' *g7p gU,uEKe1\l0<%7vktRmc.9GT[j" F)}ls'Uit+ 6?Lt-'Oxs#1aby4Ur|I ^k–Եu7>vB>ª/S;nTbKJ83Jr5M;hte;gӷ|r]<7yW3WNKivHUWh?ҫh~/Nw-ũXד`ýi+s= dz+# _`)\*.D`,~&[VxP~kv>@#ԠRGVR?JqCSÑR081>;udbԎW> wWCˁxW_᫛ SYkhHZWxi<$=bVБLP0e?PMcROݹFpk߱l_n1&vU<=cVYĀ;c.Vه1ƪHZA;rjMOusBZ`c)B O$U[ ^1Qg.ڗi[6acu?Ez|K%U?жuCV+]V7#v(,WPN}CQH$l,k9u%q\rk75m=|FWnl}kjкmYiiբspTZ@G\֫E륪g+^iVZ%׈qdAE?s,'1ҽK+iח~@k;𖜭.)[äks1_5QGG|zt{ctMI"ؑ)ʇ=+u.o2dڴuan\[uFWZR^4kF +/! u^@^$[}kvmbӂ컶 ,vqؑȭJ 9YI/L2Vݦi|UئZ#Rڳ\nNjh1Y)$4ӑC@'+ ک=nxClXV }0Rppp:Љ5-G5xdE1B-sZEZRסs|Q"1$~>"Ъ>exMWXPNOQY*e Z,LJl1$sZȰ- yɧ vRgU=ҴW2\]DYZf- UDqUxuGQi\z2%=R~WM$m畞O(bp-#Tg9w(둅^om=rh`w)#svlU:Qsr ɫ3HVA'T7dԦ$LUZ꭬-t'4nO(#ך'$RQZys:W-nι]CUtbҪ4Ks5((F]֟;d3$dՍ:H}Mtv7PtXz-s^u76v>P9i#|,JVn(Z-\tZzƓiLf0.[ԟƶsF|k,Egy&~)T+ c, > q~e&]ޤ&9\A$.Jڷmø"%+ f(.KwXYu}'H< c5-rSb9%2GL-Lsm $T-D%|:m8ʷ+]wy{9ሜu#*Iz'^meѬy=הP?ZUv4M8{I/Ύט2{_jÊTAB{9Z,n=\QUJRE_#2) Yy H׬JQ) -2+}>)7af?kF42汕6ъ99|/u[1OV6;DCҶX62@¼Of!sdGBiQܦ#@޻oҍOSdGV>edwUؼ]ªuV8gR!|]l59 d0Kj,ݦcF$ר-'}=k-$~z`T4UcϦ1;۰g B'˚+hyf,>ӡT0)mQ$I`0D64gBX)Ir}Mw:>nJ$R:/8kKV5-3)|s5ͳ_sϭTF+CڬwWG&UI2ι.n [_ę!'6ssͦ< #Sڇ>i -aE7o?"eߥ^t$ ~-f$SH/uԚXأ=һ&X`Xp"k;6@OMA]^U~xd)f}pع&CYDI?Ƽ\WyemPwS5dcA{բ[\=r%\ru6|Va]+Cmdtn$VEΗ \}U? ҃ \M$+CJ`/]Мp6Vޒ]F/U` Nk'}Bk5Xk"Ac(ZpCknۨTcY;L2;Xak:MvdTVuե \CEN\qßuQ[-kh"[4EŠ+N?JJhQIS(k_ E/jxKE"'^uG(FqCB}yGbTC7+?~QE)ns/i7võ!vv Ҝ 'lLzPCI(FHwv)q:FX(Uz[ΩSh)f.pUOBB^kNM: Lr?5dV1m;zUϴeasY!H8 +d~gRE#jk)8;1ڈ5wbHu|;oQطW7k]]89cQa#A%X+o+D.1$7cַuÎ6,&?]OR6)}HTn_=-~-PԵ(pF~SR}( Mps:Q@̏\42>l0 3w?t)!28aޛ@|0 9xjZpxW/Һ Ofqi t]ΗI-w=ڈ8t=vexu2&}0񏋯Ex6oEh דzԛztVSZI,e7FBF)GUxp ƦDz&+u?ccsW@o(,dq^ofYS]>x92=GL#HYvOU>Ƽ^<<߆w\ۑGWyqF̒hhȮCştm>H4ۣ}4T,|MnyEVIl3VVڹPݫ Ͽ@?¼_MZ"?>ʹ tGs!> sSK:__ekyp98pfe#Q#smw]iRIղFkJ(`*+k`=r ǵFh=jaLڜ}ޝPߚ ';##q@Ƒ{PzSӎ~4Qf-XKwnR;6+>/t(/޾Wd2Һ| j54^ERcEۖm#t“V[V[9;Ds> qU#ѻ@MZXԫpFҊ(/je/хh]/Z(@Ex=;zEHʤtX{?J<٫kܩ8Hi\VqI&H.?wƜ!<#4QPޯ??7r?(5U3 v1 n?EEZCOȿ#4kMƊ()UVoG)gݟany side effects such as cramping, diarrhea, nausea. None were reported. Not only has Kraemer thoroughly examined creatine, he also used it when he was a competitive athlete as did his 17-year-old daughter when she played high school tennis and his 15-year-old son when he was weight lifting. Again, no adverse side affects. Creatine does have one well-documented side effect. It causes an increase in muscle mass. When taken as prescribed it has the capacity to increase body weight by as much as seven pounds in five days.<br>Are there any long term effects? The long term effect of creatine has never been studied. However, creatine has been used in the past and without incident. Athletes in the 1940s and 1950s used it until steroids became available. They switched to steroids because they got results much faster. The Eskimos ingest up to four grams of creatine per day through their high consumption of meat and fish, twice that of Americans, and, have not had any documented ill effects.<br>How much time is considered long term? Is it 5 years, 10 years, or 50 years? The FDA has been studying creatine since it exploded onto the sports scene in 1992. Dr. Mike Stone from Appalachian State University, a leader in the field of Muscle Physiology, has been studying athletes who have been taking creatine for as long as six years. To date, there are no reports of kidney, heart or liver problems.<br>Since there is no documented evidence that creatine is a health hazard, the benefits of accelerated muscle development using creatine, far outweigh at least one alternative -